Popular Articles

Disease Markers That Will Aid Arthritis Research
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central"s open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs.

ATryn Effectively Prevents Serious Blood Clots
Data presented at the annual meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Boston show that ATryn® (Antithrombin [Recombinant]) safely prevents peri-operative and peri-partum acute deep vein thrombosis (DVT) or other venous thromboembolic events in patients with hereditary antithrombin deficiency (HD AT). ATryn is not indicated for treatment of thromboembolic events in HD AT patients. Additionally, data validate dosing algorithms that, along with AT activity monitoring, allow physicians to normalize antithrombin levels during the high-risk situations of surgery and childbirth.
News of the day
Statins May Be Linked To Muscle Damage
A recent study published in the Canadian Medical Association Journal (CMAJ) reports that patients taking statins with associated muscle complaints may have structural muscle damage.
Endocrinology

Value Of Pharmacists Will Be On Display At Annual NCSL Summit

The Alliance for Pharmaceutical Care will offer health screenings and present information on vital healthcare issues at "Pharmacist Central", the Alliance"s exhibition at the National Conference of State Legislatures (NCSL) 2009 Legislative Summit, July 20-24 in Philadelphia, Pennsylvania. The Alliance for Pharmaceutical Care is a consortium of nine national organizations working together to educate the public, policy makers and other key decision makers about the important role that pharmacists play in the ever-evolving healthcare system. At a time when the debate over healthcare reform is being played out in the nation"s Capitol and in state governments, a visit to the NCSL Summit, Pharmacist Central is a "must-do." The exhibition presents an opportunity for legislators and other attendees to witness first-hand the wide range of patient care services that pharmacists provide on a daily basis. Continuing a long tradition, pharmacists will perform health screenings and patient counseling, focusing on blood pressure, cholesterol, diabetes, bone density, body fat analysis, respiratory screening, and heartburn awareness. Pharmacists also will be available to provide medication reviews for state legislators. Participants are invited to bring a list of all current medications, including prescription drugs, over-the-counter medications, and herbal/dietary supplements. Prescription medications play an increasingly vital role in modern healthcare, and new medications continue to improve health outcomes and quality of life in patients with both acute and chronic diseases. Pharmacists, our nation"s medication experts, are on the frontlines advancing patient care, improving patient safety, and utilizing technology to improve patient outcomes. As lawmakers face the challenges of healthcare policy in their states, the Alliance will provide insight on valuable initiatives and programs that can increase access, reduce costs, and improve overall patient care and health care outcomes. Who: Pharmacists, legislators, and representatives of the Alliance for Pharmaceutical Care What: Alliance for Pharmaceutical Care exhibit at the NCSL 2009 Legislative Summit When: Tuesday, July 21 - Thursday, July 23, 2009 For more information, daily schedules and media registration, visit: http://www.ncsl.org/summit or http://www.pharmacist.com/allianceforpc Where: Booth #705 Pennsylvania Convention Center, Philadelphia, Pennsylvania American Pharmacists Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):